175 related articles for article (PubMed ID: 19895274)
1. Co-localisation of hypoxia and perfusion markers with parameters of glucose metabolism in human squamous cell carcinoma (hSCC) xenografts.
Yaromina A; Quennet V; Zips D; Meyer S; Shakirin G; Walenta S; Mueller-Klieser W; Baumann M
Int J Radiat Biol; 2009 Nov; 85(11):972-80. PubMed ID: 19895274
[TBL] [Abstract][Full Text] [Related]
2. Pimonidazole labelling and response to fractionated irradiation of five human squamous cell carcinoma (hSCC) lines in nude mice: the need for a multivariate approach in biomarker studies.
Yaromina A; Zips D; Thames HD; Eicheler W; Krause M; Rosner A; Haase M; Petersen C; Raleigh JA; Quennet V; Walenta S; Mueller-Klieser W; Baumann M
Radiother Oncol; 2006 Nov; 81(2):122-9. PubMed ID: 16956683
[TBL] [Abstract][Full Text] [Related]
3. Core needle biopsies for determination of the microenvironment in individual tumours for longitudinal radiobiological studies.
Yaromina A; Eckardt A; Zips D; Eicheler W; Schuetze C; Thames H; Baumann M
Radiother Oncol; 2009 Sep; 92(3):460-5. PubMed ID: 19682759
[TBL] [Abstract][Full Text] [Related]
4. Correlation of [18F]FMISO autoradiography and pimonidazole [corrected] immunohistochemistry in human head and neck carcinoma xenografts.
Troost EG; Laverman P; Philippens ME; Lok J; van der Kogel AJ; Oyen WJ; Boerman OC; Kaanders JH; Bussink J
Eur J Nucl Med Mol Imaging; 2008 Oct; 35(10):1803-11. PubMed ID: 18421457
[TBL] [Abstract][Full Text] [Related]
5. Does heterogeneity of pimonidazole labelling correspond to the heterogeneity of radiation-response of FaDu human squamous cell carcinoma?
Yaromina A; Hölscher T; Eicheler W; Rosner A; Krause M; Hessel F; Petersen C; Thames HD; Baumann M; Zips D
Radiother Oncol; 2005 Aug; 76(2):206-12. PubMed ID: 16024121
[TBL] [Abstract][Full Text] [Related]
6. Tumour-infiltrating CD11b+ myelomonocytes and response to fractionated irradiation of human squamous cell carcinoma (hSCC) xenografts.
Zaleska K; Bruechner K; Baumann M; Zips D; Yaromina A
Radiother Oncol; 2011 Oct; 101(1):80-5. PubMed ID: 21724288
[TBL] [Abstract][Full Text] [Related]
7. Imaging hypoxia in xenografted and murine tumors with 18F-fluoroazomycin arabinoside: a comparative study involving microPET, autoradiography, PO2-polarography, and fluorescence microscopy.
Busk M; Horsman MR; Jakobsen S; Keiding S; van der Kogel AJ; Bussink J; Overgaard J
Int J Radiat Oncol Biol Phys; 2008 Mar; 70(4):1202-12. PubMed ID: 18313528
[TBL] [Abstract][Full Text] [Related]
8. Correlation of FMISO simulations with pimonidazole-stained tumor xenografts: A question of O2 consumption?
Wack LJ; Mönnich D; Yaromina A; Zips D; Baumann M; Thorwarth D
Med Phys; 2016 Jul; 43(7):4113. PubMed ID: 27370131
[TBL] [Abstract][Full Text] [Related]
9. Changes in the fraction of total hypoxia and hypoxia subtypes in human squamous cell carcinomas upon fractionated irradiation: evaluation using pattern recognition in microcirculatory supply units.
Maftei CA; Bayer C; Shi K; Astner ST; Vaupel P
Radiother Oncol; 2011 Oct; 101(1):209-16. PubMed ID: 21641070
[TBL] [Abstract][Full Text] [Related]
10. Hypoxia-inducible factor pathway inhibition resolves tumor hypoxia and improves local tumor control after single-dose irradiation.
Helbig L; Koi L; Brüchner K; Gurtner K; Hess-Stumpp H; Unterschemmann K; Pruschy M; Baumann M; Yaromina A; Zips D
Int J Radiat Oncol Biol Phys; 2014 Jan; 88(1):159-66. PubMed ID: 24331663
[TBL] [Abstract][Full Text] [Related]
11. Bioluminescence imaging of metabolites in a human tumour xenograft after treatment with hyperthermia and/or the radiosensitizer pimonidazole.
Tamulevicius P; Streffer C
Int J Hyperthermia; 1997; 13(2):235-45. PubMed ID: 9147149
[TBL] [Abstract][Full Text] [Related]
12. Effect of cetuximab and fractionated irradiation on tumour micro-environment.
Santiago A; Eicheler W; Bussink J; Rijken P; Yaromina A; Beuthien-Baumann B; van der Kogel AJ; Baumann M; Krause M
Radiother Oncol; 2010 Nov; 97(2):322-9. PubMed ID: 20667608
[TBL] [Abstract][Full Text] [Related]
13. Comparison of [18F]FDG uptake and distribution with hypoxia and proliferation in FaDu human squamous cell carcinoma (hSCC) xenografts after single dose irradiation.
Bruechner K; Bergmann R; Santiago A; Mosch B; Yaromina A; Hessel F; Hofheinz F; van den Hoff J; Baumann M; Beuthien-Baumann B
Int J Radiat Biol; 2009 Sep; 85(9):772-80. PubMed ID: 19657862
[TBL] [Abstract][Full Text] [Related]
14. Quantitative assessment of hypoxia subtypes in microcirculatory supply units of malignant tumors using (immuno-)fluorescence techniques.
Maftei CA; Bayer C; Shi K; Astner ST; Vaupel P
Strahlenther Onkol; 2011 Apr; 187(4):260-6. PubMed ID: 21437770
[TBL] [Abstract][Full Text] [Related]
15. Hypoxia in larynx carcinomas assessed by pimonidazole binding and the value of CA-IX and vascularity as surrogate markers of hypoxia.
Hoogsteen IJ; Lok J; Marres HA; Takes RP; Rijken PF; van der Kogel AJ; Kaanders JH
Eur J Cancer; 2009 Nov; 45(16):2906-14. PubMed ID: 19699082
[TBL] [Abstract][Full Text] [Related]
16. Impact of the tumour bed effect on microenvironment, radiobiological hypoxia and the outcome of fractionated radiotherapy of human FaDu squamous-cell carcinoma growing in the nude mouse.
Zips D; Eicheler W; Brüchner K; Jackisch T; Geyer P; Petersen C; van der Kogel AJ; Baumann M
Int J Radiat Biol; 2001 Dec; 77(12):1185-93. PubMed ID: 11747543
[TBL] [Abstract][Full Text] [Related]
17. EPR Oximetry of Cetuximab-Treated Head-and-Neck Tumours in a Mouse Model.
Gustafsson H; Kale A; Dasu A; Lund A; Edqvist PH; Roberg K
Cell Biochem Biophys; 2017 Dec; 75(3-4):299-309. PubMed ID: 28756482
[TBL] [Abstract][Full Text] [Related]
18. Spatial relationship between hypoxia and the (perfused) vascular network in a human glioma xenograft: a quantitative multi-parameter analysis.
Rijken PF; Bernsen HJ; Peters JP; Hodgkiss RJ; Raleigh JA; van der Kogel AJ
Int J Radiat Oncol Biol Phys; 2000 Sep; 48(2):571-82. PubMed ID: 10974478
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of tumor lactate oxidation: consequences for the tumor microenvironment.
Busk M; Walenta S; Mueller-Klieser W; Steiniche T; Jakobsen S; Horsman MR; Overgaard J
Radiother Oncol; 2011 Jun; 99(3):404-11. PubMed ID: 21704401
[TBL] [Abstract][Full Text] [Related]
20. Differentiation status of human squamous cell carcinoma xenografts does not appear to correlate with the repopulation capacity of clonogenic tumour cells during fractionated irradiation.
Hessel F; Krause M; Helm A; Petersen C; Grenman R; Thames HD; Baumann M
Int J Radiat Biol; 2004 Oct; 80(10):719-27. PubMed ID: 15799617
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
